Transgene Biotek Q1 Results

  • BSE: 526139
  • NSE: -
  • ISIN: INE773D01018
  • Sector: Biotechnology & Drugs
BSE
6.520.03 (0.46%)
Volume16.55 K
Updated: Tue 26 Nov, 2024 | 15:29:24
NSE
This stock is not traded on NSE
Today: 6.51
6.81
52-Wk: 5.79
12.46

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Transgene Biotek Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
    Total Revenue 0.050.00-%0.10-%
    Selling/ General/ Admin Expenses Total 0.080.08-%0.08-%
    Depreciation/ Amortization 0.021.24-%0.02-%
    Other Operating Expenses Total 0.380.09-%0.15-%
    Total Operating Expense 0.481.47-%0.25-%
    Operating Income -0.44-1.47-%-0.15-%
    Net Income Before Taxes 0.20-1.47-%-0.14-%
    Net Income 0.20-1.47-%-0.14-%
    Diluted Normalized EPS 0.03-0.20-%-0.02-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts